GH Research
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 months.
- Its last 9 Sell calls were actually followed by a +10% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -6.8% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 02:27 UTC
Data coverage: 4 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation N/A
How expensive the stock is versus earnings, sales and its own 5-year history.
Not enough data to grade this factor.
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability D
How much profit the business keeps from each dollar of sales and capital.
| Return on equity | -21.0% | Better than 16% |
| Return on invested capital | -23.2% | Better than 12% |
Momentum C
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -38.1% | Better than 12% |
| 6-month return | -20.8% | Better than 26% |
| 12-month return (ex latest month) | 28.9% | Better than 69% |
| Distance below 52-week high | 44.2% | Better than 24% |
Financial Health A-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 34.1x | Better than 99% |
| Debt to assets | 0.2% | Better than 98% |
| Interest coverage | -1,377.8x | Better than 2% |
Analyst View A+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 187.1% | Better than 94% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 18.56
- Open
- 18.32
- Day range
- 17.29 - 18.32
- Avg price
- 17.62
- Volume
- 299.46K
- Turnover
- 5.27M
- Turnover ratei
- 0.89%
- Volume ratioi
- 0.65
- Amplitudei
- 5.55%
- 52-week rangei
- 12.04 - 31.44
Valuation
- P/Ei
- -22.19
- P/E (TTM)i
- -18.65
- P/Bi
- 3.45
- EPSi
- -0.79
- Book value / shi
- 5.08
- Net profit
- -54.25M
- Net assets
- 349.01M
Share structure
- Market cap
- 1.20B
- Float capi
- 590.64M
- Shares out
- 68.68M
- Float sharesi
- 33.69M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2021-06-25
44.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-2.91M net over the window
Short interest
- Shares short
- 2.08M
- % of floati
- 3.03%
- Days to coveri
- 6.51
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of GH Research (GHRS)?
GH Research last traded at 17.53. This page shows a periodic quote snapshot. Check the displayed quote time.
What is GH Research's market cap?
About 1.20B.
What is the P/E ratio of GH Research?
The trailing twelve-month P/E is -18.65. The Valuation tab shows it against the stock's own five-year range.
Does GH Research pay a dividend?
GH Research does not currently pay a regular dividend.
Is GH Research a buy according to analysts?
The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 50.33, which implies 187.1% upside from the current price. This is not investment advice.
What is GH Research's StockVane Quant Rating?
The StockVane Momentum strategy currently rates GH Research a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
GH Research discussion 0 comments